ZQZhen Qi

Zhen Qi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhen Qi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    BCL11B predetermines a persister state in breast cancer that is reversed by TNFα

    by Zhen Qi, Gunsagar S. Gulati, Rachel Gleyzer, Angera H. Kuo, Shaheen S. Sikandar, Huiru Bai, William Hai Dang Ho, Dalong Qian, Frederick M. Dirbas, Aaron M. Newman, et al.

    The frequent development of chemoresistance in cancer presents a major clinical challenge, yet the underlying causes of heterogeneous drug responses remain largely elusive. Here, we systematically assessed the cellular differentiation status of human breast cancer cells using single-cell atlases and identified a distinct population of immature basal-like cancer cells marked by BCL11B . Notably, higher levels of BCL11B + cancer cells are significantly associated with early relapse in patients with breast cancer who received chemotherapy. Functioning as a central regulator, B-cell lymphoma/leukemia 11B (BCL11B) delineates an immature cell state that preferentially transitions to a drug-resistant persister state during treatment through multiple preexisting and adaptive drug resistance programs. The cytokine tumor necrosis factor–α (TNFα) is revealed as a natural inhibitor of BCL11B and can directly reverse the emergence of chemoresistant persister cells. Therefore, we identify BCL11B as an unappreciated predeterminant of drug response and a therapeutic target for a subset of patients with breast cancer at high risk of developing chemoresistance.

  • Top Cited Papers
    Open Access

    Improved reconstruction of single-cell developmental potential with CytoTRACE 2

    by Minji Kang, Gunsagar S. Gulati, Erin L. Brown, Zhen Qi, Susanna Avagyan, Jose Juan Almagro Armenteros, Rachel Gleyzer, Wubing Zhang, Chloé B. Steen, Jeremy Philip D’sIlva, et al.

    While single-cell RNA sequencing has advanced our understanding of cell fate, identifying molecular hallmarks of potency—a cell’s ability to differentiate into other cell types—remains a challenge. Here we introduce CytoTRACE 2, an interpretable deep learning framework for predicting absolute developmental potential from single-cell RNA sequencing data. Across diverse platforms and tissues, CytoTRACE 2 outperformed previous methods in predicting developmental hierarchies, enabling detailed mapping of single-cell differentiation landscapes and expanding insights into cell potency.